TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$1.16
-0.01 (-0.85%)
Financial Highlights (FY 2026)
Revenue
37.7K
Net Income
-18,165,440
Gross Margin
614,639.0%
Profit Margin
-51,035.7%
Rev Growth
-74.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 614,639.0% 614,641.1% 43.4% 43.4%
Operating Margin -48,157.1% -43,341.6% 35.9% 36.7%
Profit Margin -51,035.7% -48,483.9% 30.8% 28.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 37.7K 150.4K 15.27M 16.61M
Gross Profit 231.98M 924.24M 6.63M 7.21M
Operating Income -18,175,949 -65,172,725 5.47M 6.09M
Net Income -18,165,440 -65,135,043 4.70M 4.66M
Gross Margin 614,639.0% 614,641.1% 43.4% 43.4%
Operating Margin -48,157.1% -43,341.6% 35.9% 36.7%
Profit Margin -51,035.7% -48,483.9% 30.8% 28.0%
Rev Growth -74.9% -74.9% -3.4% +2.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 9.67M 9.42M
Total Equity 27.14M 24.11M
D/E Ratio 0.36 0.39
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -17,140,972 -64,876,188 6.30M 6.21M
Free Cash Flow 4.04M 4.00M